Individualised breast cancer risk assessment model for BreastScreen Norway

Bookmark and Share
Published: 17 Nov 2022
Views: 30
Dr Javier Louro - Hospital del Mar Medical Research Institute, Barcelona, Spain.

Dr Javier Louro speaks to ecancer about an individualised breast cancer risk assessment model for women attending screening in BreastScreen Norway.

This study includes data from around 50,000 women who were taking part in BreastScreen Norway between 2007 and 2020. It found that the risk of developing breast cancer over a period of four years ranged from as low as 0.22% for some people up to 7.43% for others, with an average (median) risk of 1.10%.

Dr Louro says that the team have successfully developed and validated a model to estimate breast cancer risk in women participating in BreastScreen Norway. He mentions that several breast cancer risk prediction models have been created, but this is one of the first models designed to guide breast screening strategies over a person’s lifetime using real data from a screening programme.

It is also the first model developed using data from BreastScreen Norway. He concludes by talking about the implications of this study on the future screening of breast cancer.

Read the full story here.